A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer
Status:
Terminated
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
This is a parallel arm study to evaluate AGS-8M4 administered in combination with
chemotherapy in subjects with ovarian cancer. AGS-8M4 will be administered as an IV infusion
until disease worsens.